文献速递肝胆胰外科胃肠外科围术期管理与 ERAS

胰十二指肠切除术中空肠造瘘管的预测因素与结局

Predictors and outcomes of jejunostomy tube placement at the time of pancreatoduodenectomy.
PubMed 文献 · Surgery · 2019-05-07

基于美国外科医师学会NSQIP数据库2014-2015年3600例胰十二指肠切除术患者,8.9%同期放置空肠造瘘管。放置与白色人种、低术前白蛋白、新辅助放疗及术中输血相关,但与临床相关术后胰瘘或胃排空延迟的风险因素数量无关;造瘘与总并发症和住院时间增加相关,但与死亡率无关。在低白蛋白或发生上述并发症的患者中,造瘘与不良结局无关。

要点

  • 空肠造瘘放置率8.9%,主要预测因素为人种、低白蛋白、新辅助放疗和术中输血。
  • 造瘘放置与临床相关胰瘘或胃排空延迟的风险因素数量无关,提示实践模式差异。
  • 造瘘与总并发症和住院时间增加相关,但在高危患者中未增加死亡率。

核心结论

  • 胰十二指肠切除术中空肠造瘘管的放置并非由临床相关术后胰瘘或胃排空延迟的风险因素驱动,提示实践模式起一定作用。
  • 在术前白蛋白低或发生临床相关术后胰瘘/胃排空延迟的患者中,空肠造瘘与更差结局无关,支持按指南选择性使用。

研究设计与样本

  • 回顾性队列研究,使用美国外科医师学会NSQIP及胰腺切除术靶向参与用户文件,纳入2014-2015年行胰十二指肠切除术的3600例患者。
  • 采用多变量逻辑回归分析与空肠造瘘管放置相关的因素及术后结局。

主要发现

  • 3600例患者中8.9%放置了空肠造瘘管。
  • 在术前白蛋白低或发生临床相关术后胰瘘/胃排空延迟的患者中,空肠造瘘使用与并发症或死亡率无关。

临床怎么用

  • 对于胰十二指肠切除术后营养不良高风险患者,可考虑按指南选择性放置空肠造瘘管。
  • 不应仅基于临床相关术后胰瘘或胃排空延迟的风险因素数量决定是否放置空肠造瘘管。
  • 对于术前白蛋白低或术后发生胰瘘/胃排空延迟的患者,空肠造瘘未显示与更差结局相关,可个体化使用。

局限性

  • 回顾性研究设计,可能存在未测量的混杂因素。
  • 使用行政数据库,可能受编码准确性限制。
  • 研究期间为2014-2015年,实践模式可能已变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinically relevant postoperative pancreatic fistula and delayed gastric emptying cause substantial morbidity after pancreatoduodenectomy. Per international guidelines, the placement of jejunostomy tubes may be considered for patients at risk for malnutrition, such as those with a high risk for clinically relevant postoperative pancreatic fistula and related complications. This study determined predictors and postoperative outcomes of jejunostomy tube placement. METHODS: Patients undergoing pancreatoduodenectomy in 2014 to 2015 were identified using the American College of Surgeons National Surgical Quality Improvement Program and Procedure-Targeted Pancreatectomy Participant Use Files. Multivariable logistic regressions were used to identify factors associated with concurrent jejunostomy tube placement and postoperative outcomes. RESULTS: Of 3,600 patients, 8.9% underwent jejunostomy tube placement. Patients given a jejunostomy tube were more likely white (odds ratio 1.46, P = .016), to have low preoperative serum albumin levels (odds ratio 2.13, P < .001), to have received neoadjuvant radiotherapy (odds ratio 2.14, P < .001), and to have received an intraoperative transfusion (odds ratio 1.50, P = .004). We observed no association between jejunostomy tube placement and an increasing number of risk factors for clinically relevant postoperative pancreatic fistula (P = .96) or delayed gastric emptying (P = .54). Overall, jejunostomy tube placement was associated with increased morbidity (odds ratio 1.34, P = .020) and duration of stay (P < .001), but not mortality (P = .12). Among patients with low serum albumin or those who developed clinically relevant postoperative pancreatic fistula or delayed gastric emptying, jejunostomy tube utilization was not associated with morbidity or mortality. CONCLUSION: Jejunostomy tube placement during pancreatoduodenectomy was not driven by risk factors for clinically relevant postoperative pancreatic fistula or delayed gastric emptying, suggesting that practice patterns play a role. Among patients with at-risk preoperative albumin or who developed these complications, jejunostomy tube placement was not associated with worse outcomes, supporting selective utilization per guideline recommendations.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Song Y, Tieniber AD, Vollmer CM, et al. Predictors and outcomes of jejunostomy tube placement at the time of pancreatoduodenectomy. Surgery. 2019. PMID: 31076092. doi:10.1016/j.surg.2019.03.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。